FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
ABBOTINDIA
2012345678900123456789,301234567892012345678900123456789.3012345678900123456789
+82.50 (+0.41%)
Previous Close: 20237.8
1D
5D
1M
3M
1Y
5Y
Popular Posts

Stock Sangreh

Stock Sangreh

Possible trending stocks for next week #ABBOTINDIA #BALRAMCHIN #COLPAL #DABUR #HCLTECH #HDFC #INFY #JKCEMENT #MARICO #MPHASIS #NAUKRI #NMDC #POWERGRID #RAMCOCEM TCS ULTRACEMCO VEDL

vijay jaria

This view is based on volume, oi, delivery data & price action. ALL Posts are for educational purposes only & not any recommendation POSSIBLE BEARISH FOR COMING DAYS-> #ABBOTINDIA #HAVELLS #IGL #LALPATHLAB #LTI #LTTS #MARICO #NAUKRI #PERSISTENT #STAR

vijay jaria

Axis Direct target on ABBOTINDIA Date: 08-Jan-22 Broker: Axis Direct Price @ Call: 18325 Target: 20000 Potential: 9.14% Recommendation: BUY

ReportBot

Sharekhan target on ABBOTINDIA Date: 13-Dec-21 Broker: Sharekhan Price @ Call: 18343 Target: 22780 Potential: 24.19% Recommendation: BUY

ReportBot

"Stocks Good to Buy" in Positional Trades Stocks Good to Buy #ABBOTINDIA 22,581.25 #ANGELBRKG 1,455.00 #DIXON 4,865.85 #ROUTE ROUTE & more .. (Swing,Momentum,Trending,Invest) channel on FrontPage

Jagdish Jha

We Suggested It On 20520 Now Trading At 20350 And Our Target Is 21500 🚀🚀🚀🚀 #ABBOTINDIA Those Who Are Following And Supporting Me In FrontPage Has Feeled Our Accuracy Join Us

Shyamkumar S

Axis Direct target on ABBOTINDIA Date: 22-Sep-21 Broker: Axis Direct Price @ Call: 20500 Target: 20000 Potential: -2.44% Recommendation: HOLD

ReportBot

#ABBOTINDIA Strong growth rates expected to drive Abbott India's outperformance Ram Prasad Sahu | 15/09/2021 | 2 hours ago Since its August lows, the Abbott India stock has been on an upswing gaining about 21 per cent on steady June quarter results, brokerage upgrades and expectations of double digit growth going ahead. The momentum for the stock, which hit its all-time high on Tuesday, is expected to continue given the robust sales posted in August. For the three months ended August, the company outperformed the pharma market with a growth of 22 per cent as compared to 15 per cent growth for the broader market. Barring the vitamins, minerals and nutrition segment which saw a drop in sales, other therapies reported an uptick. Growth was led by larger categories of anti-diabetic and gastrointestinal therapies and the trend of key brands growing faster than the market is expected to continue. Abdulkader Puranwala of Anand Rathi Research expects the pharma market to grow in mid-teens going ahead, in line with its past average. He expects chronic therapies to outstrip acute therapies in the long run as emerging lifestyle diseases boost demand for such drugs. He prefers companies with strong chronic therapy ranges and has a positive view on Abbott India. Eight out of the company’s top ten brands are in the chronic/sub-chronic segments. Most analysts expect the company to post double digit growth rates and outperform the pharma market by 200-300 basis points. Highlighting key triggers for the stock, analysts at ICICI Securities believe future launches from key divisions, along with brand extensions and access to innovative molecules from global parent will drive growth. Further, its strong growth track in power brands and capability in new launches on a fairly consistent basis (+100 launches in the last 10 years) would be another factor that should help it maintain growth, they add. The company launched 15 products in FY21 and is expected to match last year’s run rate in the current financial year as well. While the company grew its revenues at 10.5 per cent over the FY16-21 period, analysts expect growth to be at 13 per cent over the next couple of years led by new introductions as well as price hikes. In addition to top line growth, a focused drive to improve operational efficiencies, cost reduction, and positive product mix would result in margin improvement, according to Cyndrella Carvalho of Centrum Research. Higher proportion of brands as compared to its insulin portfolio (trading business) should aid profitability. Margins are expected to increase by 300 basis points to 24.3 per cent by FY23 from current levels. Though a debt free balance sheet, the highest return ratios in the domestic pharma sector, strong growth rates and digital initiatives are positive, the stock after the recent rally is available at 45 times its FY23 earnings estimates. This is at a premium to its five-year average and makes it the most expensive among large cap pharma names. Investors can look at the company on dips for a medium to long term holding period.

Sridhar Balakrishnan

COMPANY NAME RESULT DATE #AARTIIND - 18 May 2021 #ABBOTINDIA - 18 May 2021 #ARFIN - 18 May 2021 #ASTRAL - 18 May 2021 #BIOGEN - 18 May 2021 #BRIGADE - 18 May 2021 #CANBK - 18 May 2021 #CENTENKA - 18 May 2021 #CHALET - 18 May 2021 #COROENGG - 18 May 2021 #DIAMINESQ - 18 May 2021 #DOLAT - 18 May 2021 #ESTER - 18 May 2021 #GLAXO - 18 May 2021 #GUJALKALI - 18 May 2021 #GULPOLY - 18 May 2021 #IIFLWAM - 18 May 2021 #JBMA - 18 May 2021

vijay jaria

Gyanee

Indyan

"#Stocks looking good to buy/add 11 Dec 2020" in Positional Trades (Swing,Momentum,Trending,Invest) channel on FrontPage https://front.page/jsmc-positional-trades/1772217 #FrontPage #BURGERKING 135 #LT 1255 #IRCTC 1476 #ABBOTINDIA 16482 #BATAINDIA 1622 #ICICIBANK 525 #NESTLEIND 18625 & more early picks.

Jagdish Jha

Alpha Signals

#ABBOTINDIA Buy CMP To 15800 sl 15500 TG 18000

Elliott Wave

Elliott Wave

Pearl Kaur

Being Trader

https://www.moneycontrol.com/news/business/markets/top-10-stocks-to-look-at-based-on-warren-buffetts-investment-methodology-5773561.html #ABBOTINDIA #ALKYLAMINE #AMRUTANJAN #BRITANNIA #JBCHEPHARM

NewsBot

Pearl Kaur

https://www.moneycontrol.com/news/business/markets/as-market-valuations-turn-expensive-brokerages-pick-these-27-stocks-5682731.html #ABBOTINDIA #ALKEM #AUBANK #BALKRISIND #BHARTIARTL

NewsBot

#ABBOTINDIA #InvestmentIdeas #Abbott India (Analysis) - Distributes Novo Nordisk’s insulin products in India - Top 10 brands are leaders in respective segments - Leading player in thyroid (50%+ market share) - 24% portfolio under National List of Essential Medicines (NLEM)

Sridhar Balakrishnan

https://economictimes.indiatimes.com/markets/stocks/recos/outperformer-rating-for-abbott-india-target-price-rs-18130-clsa/articleshow/76293945.cms #ABBOTINDIA

NewsBot

Trade Wizards-display-image
Reputation: 7,749  •  Nov 24 2:43 AM

#ABBOTINDIA CHART LOOKS CRAZY UPSIDE WITH STRONG BREAKOUT

VCP PATTERN WITH GOLDEN CROSSOVER IN ALL TF's
Chartbusters - chart - 16805847
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Nov 18 4:11 AM
Hold Abbott India, target price Rs 21725: ICICI Direct
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 41423.28 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Nov 16 2:31 AM
Buy Abbott India, target price Rs 23100: Centrum Broking
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 41757.96 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Nov 14 2:11 AM
Corporate Radar: Power Grid to go ex-dividend; Arfin India stock split & more
Shares of Arfin India will trade ex-split in the ratio of 1:10. The companys shares will be sub-divided from a face value of Rs 10 to Re 1. Also, shares of Compuage Solutions will go ex-rights for the rights issue of eight shares for every 25 shares held offered at the rate of Rs 20 per share.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Oct 3 5:01 AM
Hold Abbott India, target price Rs 21140: ICICI Direct
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 40626.54 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
Jagdish Jha-display-image
Reputation: 8,150  •  Sep 29 6:42 AM
Like
Comment
Share
Add a comment
Jagdish Jha-display-image
Reputation: 8,150  •  Sep 29 6:38 AM

#ABBOTINDIA22SEP19000CE 45 : Hits 60, next 75 & more
Like
Comment
Share
Add a comment
Stock Sangreh-display-image
Reputation: 5,476  •  Sep 20 10:37 AM

Best setup to go short:
1. Stock is near their strong resistance, can expect fall from here.
2. TSI is negative
3. RSI is below 50
Entry price: 18200-18300
SL: 18400
Target: 17500/16500
#InvestmentIdeas #InvestingUniversity #TradingUniversity @stocksangreh

Discla......read more
Chartbusters - chart - 12742587
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Sep 12 5:11 AM
No reason for pessimism in Indian IT services; plan to invest more in pharma: Saurabh Mukherjea
“The whole world is trying to replace China in both its formulation – API, and its intermediate supply chain. We already have significant investments in firms like GMM, Alkyl, Divis. We are considering making some more investments in the space but as we invest in companies with barriers to entry with moats and that require careful work at the down level.”
The Economic Times
Like
Comment
Share
Add a comment
Stock Sangreh-display-image
Reputation: 5,476  •  Aug 27 12:05 PM

Stock is near their strong support zone. We might see reversal from here. Risk reward is favorable.
Entry price: 18400/18500
SL: 18000
Target: 20000/23000
NOTE: Indicators are not supporting on daily chart.
#InvestmentIdeas #InvestingUniversity #TradingUniversity

......read more
Chartbusters - chart - 11945234
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Aug 25 5:16 AM
Saurabh Mukherjea on why he exited La Opala, Abbott India & entered ICICI Lombard
“We built up a position in ICICI Lombard. We had a smaller position last year. It has been ramped up significantly over the last six months. A lot of stuff is happening in IRDA which is very encouraging for high quality multiline insurance companies like ICICI Lombard. We hope to make more money from it in the years ahead.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Aug 23 4:46 AM
Buy Abbott India, target price Rs 20800: Axis Securities
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 39627.82 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
vijay jaria-display-image
Reputation: 29,309  •  Aug 21 10:00 AM
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Aug 13 4:01 AM
BEML, IGL, Zomato rally up to 24% this week; Natco, Yes Bank among top laggards on BSE500
Among sectoral indices, BSE Metal index zoomed 5 per cent, followed by a 4 per cent rally in Capital Goods and Power indices each. Energy, utilities, finance and industrial stocks added 3 per cent each during the week. In the BSE 500 index, about 290 stocks settled in the green, whereas others dropped during the four trading sessions; 15 stocks were able to register double-digit gains, whereas only two plunged 10 per cent or more.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Aug 4 1:11 AM
SGX Nifty up 60 points; here's what changed for market while you were sleeping
Asian stocks rose Thursday morning as traders tracked a rally on Wall Street fuelled by a drop in oil prices and better-than-expected US economic data. MSCI's index of Asia-Pacific shares outside Japan was up by 0.76 per cent.
The Economic Times
Like
Comment
Share
Add a comment
M
Reputation: 968  •  Jul 15 4:52 AM

ABBOTT INDIA
NOW @ 19700
💚💚💚💚💚💚💚💚💚💚
ALL PLAYERS CAN BOOK PARTIAL PROFIT
💰💰💰💰💰💰💰💰💰💰
CALL WAS GIVEN @ 18900
WE HIT'S 8 CENTURIES
🏏🏏🏏🏏🏏🏏🏏🏏🏏
800 POINTS
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Jul 13 4:21 AM
Buy Abbott India, target price Rs 20560: ICICI Direct
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 41234.27 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Jul 12 10:16 AM
3 stocks that Team Prashant Jain entered in June; 5 shares it exited
Jain is Executive Director and Chief Investment Officer at HDFC AMC.Data showed the mutual fund house bought a 0.02 per cent stake or 1,97,807 shares in Shriram City Union Finance worth Rs 32.85 crore. It added Sanofi, buying 8,365 shares worth Rs 5.38 crore. It also entered Metropolis Healthcare with 3,600 shares worth Rs 50 lakhs.
The Economic Times
Like
Comment
Share
Add a comment
M
Reputation: 968  •  Jun 30 2:45 AM

POSITIONAL LOOKS GOOD
ABBOTT INDIA
CMP.18900
SUPPORT 17000
RESISTANCE OPEN TO SKY
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Jun 29 2:21 AM
Ahead of Market: 10 things that will decide stock action on Thursday
"The present range-bound movement could continue for the next 1-2 sessions and immediate supports to be watched around 15,600-15,650 levels. On the flip side, a decisive move above 15,850-15,900 levels is likely to open a sustainable upside for the market," he said.
The Economic Times
Like
Comment
Share
Add a comment
Jagdish Jha-display-image
Reputation: 8,150  •  Jun 29 7:22 AM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Jun 12 10:06 AM
Ahead of Market: 12 things that will decide stock action on Monday
The benchmark appears to be moving towards the support zone between 15,900 and 16,100. Despite the fact that this week's trading patterns suggest additional downside, the overall bearish momentum has moderated as Nifty is currently trading above the falling resistance line,” Yesha Shah, Head of Equity Research, Samco Securities said.
The Economic Times
Like
Comment
Share
Add a comment
URFinMaster-display-image
Reputation: 11,751  •  May 19 4:46 AM


18300 - 18500 Weekly close... then 💥💥💥💥 20.5K!

Sweet.
ABBOTINDIA - 9365954
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  May 17 3:51 AM
Ahead of Market: 12 things that will decide D-Street action on Wednesday
Momentum indicator Moving Average Convergence Divergence (MACD) showed a bullish trade setup on the counters of Oil India, Abbott India, Coromandel International, Dhani Services, Nocil and Zensar Tech.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  May 17 11:41 AM
Abbott India Q4 results: Net profit up 39% at Rs 211 crore
Revenue from operations rose to Rs 1,255 crore in the period under review as compared with Rs 1,096 crore in the year-ago period, it added.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  May 17 1:36 AM
SGX Nifty up 45 points; here's what changed for market while you were sleeping
Major Asian stocks rose in morning trade on Tuesday despite Wall Street stocks finishing mostly lower on weak Chinese economic data. MSCI's index of Asia-Pacific shares outside Japan was up 1.01 per cent.
The Economic Times
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,221  •  May 15 12:30 PM

#ABBOTINDIA will declare results on May 17, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  May 9 2:21 AM
Nationwide shortage of baby formula in U.S has left mothers struggling to provide for their babies
Baby formula once stocked on grocery store shelves across the country is now empty or nearly empty. Many parents in the United States, including a mother in Tennessee, are finding it difficult to find baby formula amid the current shortage.
The Economic Times
Like
Comment
Share
Add a comment
Tanay Mitkari-display-image
Reputation: 632  •  Apr 20 5:04 AM

Can't find a reason of falling for this fundamentally strong stock #ABBOTINDIA
The YOY sales are really good, also increasing OPM, still stock has fallen soo badly.

Please let me know what could be the reason behind this.

Also I could see breakout of downtrend, and if it forms......read more
Chartbusters - chart - 8784392
Like
1 Comment
Share
Add a comment
Technical Analysis -display-image
Reputation: 428  •  Apr 18 3:37 AM

#ABBOTINDIA - DAILY (19 APRIL)
------------
🔺RESISTANCE - 17945
🔺SUPPORT - 16800
------------
⬇️IF IT BREAKS SUPPORT & SUSTAIN BELOW - 17300 🔽 - SELL
⬆️IT TAKES SUPPORT & SUSTAIN ABOVE - 17300 🔼 - BUY
------------
☮️BIG FULL RED CANDLE, HUGE FII SELL......read more
Chartbusters - chart - 8745141
Like
Comment
Share
Add a comment
Technical Analysis -display-image
Reputation: 428  •  Apr 18 1:24 AM

ABBOTINDIA - DAILY (19 APRIL)
🔺RESISTANCE - 17940
🔺SUPPORT - 16680
🔷IF IT BREAKS SUPPORT & SUSTAIN BELOW - 17310
🔷THEN AGAIN GO DOWN 🔽 NEXT SUPPORT - 17940
✅IF IT TAKES SUPPORT & SUSTAIN ABOVE - 17310
✅THEN AGAIN GO UP 🔼 NEXT RESIS......read more
Chartbusters - chart - 8744436
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Apr 11 9:36 AM
Abbott launches Arachitol Gummies in India
According to a recent study, despite India being a tropical country with an abundance of sunlight, 76 per cent Indians have Vitamin D deficiency and insufficiency, especially in the age group of 18-30 years.
The Economic Times
Like
Comment
Share
Add a comment
M
Reputation: 968  •  Apr 8 2:43 AM

# POSITIONAL LOOKS GOOD
ABBOT INDIA
CMP. 18200 - 300
SUPPORT. 17500
RESISTANCE OPEN TO SKY
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,713  •  Feb 11 10:30 AM

ICICIdirect.com target on ABBOTINDIA
Date: 11-Feb-22 Broker: ICICIdirect.com Price @ Call: 16609 Target: 19840 Potential: 19.45% Recommendation: BUY
1 Like
Comment
Share
Add a comment
Srksagar-display-image
Reputation: 64,792  •  Feb 10 11:04 AM
link
YouTube
Share your videos with friends, family, and the world
youtu.be
Like
Comment
Share
Add a comment
Traders Premier -display-image
Reputation: 2,324  •  Feb 9 12:21 PM

Positional Call NSE:ABBOTINDIA CMP 16750 buy above 20196.7 stop loss 15514 #turtletrade Educational purpose only
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,221  •  Feb 7 12:30 PM

#ABBOTINDIA will declare results on Feb 9, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
vijay jaria-display-image
Reputation: 29,309  •  Jan 23 3:53 AM

This view is based on volume, oi, delivery data & price action.
ALL Posts are for educational purposes only & not any recommendation
POSSIBLE BEARISH FOR COMING DAYS->
#ABBOTINDIA #HAVELLS #IGL #LALPATHLAB #LTI #LTTS #MARICO #NAUKRI #PERSISTENT #STAR
1 Like
Comment
Share
Add a comment
URFinMaster-display-image
Reputation: 11,751  •  Jan 19 2:25 AM

#ABBOTINDIA or Abort ???

Down 30% from peak.

Weekly close below 16880 then Quit India!

😂😂😂😂

#NIFTY50
ABBOTINDIA - 7013929
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,713  •  Jan 11 7:30 AM

Axis Direct target on ABBOTINDIA
Date: 08-Jan-22 Broker: Axis Direct Price @ Call: 18325 Target: 20000 Potential: 9.14% Recommendation: BUY
8 Likes
Comment
Share
Add a comment
A
Reputation: 80  •  Dec 31, 2021 4:35 AM
Abhishek Malasi in SUNPHARMA
#PHARMA fireworks 🔥 in entire sector. #SUNPHAR...
Like
Comment
Share
Add a comment
A
Reputation: 80  •  Dec 29, 2021 9:07 AM
Abhishek Malasi in ABBOTINDIA
#PHARMA sector looks lucrative for buying. Top ...
Like
Comment
Share
Add a comment
A
Reputation: 80  •  Dec 27, 2021 4:14 AM
Like
Comment
Share
Add a comment
Intraday Traders FnO-display-image
Reputation: 3,616  •  Dec 23, 2021 8:15 AM
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,713  •  Dec 17, 2021 6:30 AM

Sharekhan target on ABBOTINDIA
Date: 13-Dec-21 Broker: Sharekhan Price @ Call: 18343 Target: 22780 Potential: 24.19% Recommendation: BUY
2 Likes
Comment
Share
Add a comment
P
Reputation: 32  •  Nov 26, 2021 4:02 AM
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,713  •  Nov 16, 2021 12:30 PM

Axis Direct target on ABBOTINDIA
Date: 15-Nov-21 Broker: Axis Direct Price @ Call: 19747 Target: 22400 Potential: 13.43% Recommendation: BUY
Like
Comment
Share
Add a comment
Ska-display-image
Reputation: 0  •  Nov 16, 2021 1:50 AM
Ska in ABBOTINDIA
Trade entered: Buy ABBOTINDIA NOV21 20000 CE @3...
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,754  •  Nov 15, 2021 4:06 AM
Buy Abbott India, target price Rs 22400: Axis Securities
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 42232.99 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
Harry-display-image
Reputation: 1,825  •  Nov 14, 2021 9:23 AM

*Abbott India Ltd.* | *CMP* Rs. 19783 | *M Cap* Rs. 42037 Cr | *52 W H/L* 23934/13835
(Nirmal Bang Retail Research)
*Result inline with Expectation*
Revenue from Operations came at Rs. 1222.1 Cr (0.3% QoQ, 15.9% YoY) vs expectation of Rs. 1205.5 Cr, QoQ Rs. 1217.8 Cr, YoY Rs. 105......read more
1 Like
Comment
Share
Add a comment